En-Rung Chiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
En-Rung Chiang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Hsiao-Li Ma
Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan
2 shared publicationsHsuan-Hsiao Ma
Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan
2 shared publications- Jung-Pan Wang
Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan
2 shared publications Kun-Hui Chen
Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan
2 shared publications- Szu-Hsien Wu
Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
2 shared publications - Yu-Ting Liao
Department of Orthopaedics & Traumatology, Taipei Veterans General Hospital, Taipei 112, Taiwan
2 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1664
Leukocyte-Rich Platelet-Rich Plasma Improves Cartilage Repair After High Tibial Osteotomy: A Second-Look Arthroscopic Study
Background: High tibial osteotomy (HTO) is commonly performed to manage medial compartment knee osteoarthritis by correcting mechanical alignment; however, the role of adjunctive regenerative therapies remains uncertain. Methods: This retrospective study compared leukocyte-rich platelet-rich plasma (LR-PRP) with leukocyte-poor PRP (LP-PRP) in patients undergoing HTO. Forty patients were allocated into three groups: HTO alone (n = 10), HTO with LR-PRP (n = 20), and HTO with LP-PRP (n = 10). Clinical outcomes were assessed preoperatively and at 12 months using the Visual Analog Scale, Oxford Knee Score, and Western Ontario and McMaster Universities Osteoarthritis Index. Cartilage repair appearance was evaluated through second-look arthroscopy using the ICRS grading and Koshino staging systems. Multivariable analysis of covariance (ANCOVA), adjusting for baseline imbalances, was employed to evaluate postoperative outcomes. Results: All groups demonstrated significant improvements in pain and function (p < 0.05), with no significant differences among groups. However, Group B exhibited a greater shift toward lower ICRS grades than Group A (p < 0.05), whereas no significant difference was found between Groups C and A. Arthroscopic findings revealed more complete defect coverage and improved structural integrity in the LR-PRP group. Conclusions: These findings demonstrate a clear discrepancy exists between clinical and structural outcomes; while HTO drives substantial and comparable short-term functional improvements across all cohorts, adjunctive LR-PRP is positively associated with a significantly enhanced arthroscopic cartilage repair appearance compared to LP-PRP or HTO alone. Further prospective studies are needed to validate these findings and elucidate the underlying biological mechanisms.
- 24 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1664
Open AccessLeukocyte-Rich Platelet-Rich Plasma Improves Cartilage Repair After High Tibial Osteotomy: A Second-Look Arthroscopic Study
Background: High tibial osteotomy (HTO) is commonly performed to manage medial compartment knee osteoarthritis by correcting mechanical alignment; however, the role of adjunctive regenerative therapies remains uncertain. Methods: This retrospective study compared leukocyte-rich platelet-rich plasma (LR-PRP) with leukocyte-poor PRP (LP-PRP) in patients undergoing HTO. Forty patients were allocated into three groups: HTO alone (n = 10), HTO with LR-PRP (n = 20), and HTO with LP-PRP (n = 10). Clinical outcomes were assessed preoperatively and at 12 months using the Visual Analog Scale, Oxford Knee Score, and Western Ontario and McMaster Universities Osteoarthritis Index. Cartilage repair appearance was evaluated through second-look arthroscopy using the ICRS grading and Koshino staging systems. Multivariable analysis of covariance (ANCOVA), adjusting for baseline imbalances, was employed to evaluate postoperative outcomes. Results: All groups demonstrated significant improvements in pain and function (p < 0.05), with no significant differences among groups. However, Group B exhibited a greater shift toward lower ICRS grades than Group A (p < 0.05), whereas no significant difference was found between Groups C and A. Arthroscopic findings revealed more complete defect coverage and improved structural integrity in the LR-PRP group. Conclusions: These findings demonstrate a clear discrepancy exists between clinical and structural outcomes; while HTO drives substantial and comparable short-term functional improvements across all cohorts, adjunctive LR-PRP is positively associated with a significantly enhanced arthroscopic cartilage repair appearance compared to LP-PRP or HTO alone. Further prospective studies are needed to validate these findings and elucidate the underlying biological mechanisms.
- Open Access
- 7 January 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Five-year follow-up of surgical treatment for native shoulder septic arthritis in patients under 70 years
Native Shoulder Septic Arthritis (NSSA) is uncommon, even among immunocompromised populations. Despite its rarity, clinical management remains complex, and
- 7 January 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Open AccessFive-year follow-up of surgical treatment for native shoulder septic arthritis in patients under 70 years
Native Shoulder Septic Arthritis (NSSA) is uncommon, even among immunocompromised populations. Despite its rarity, clinical management remains complex, and
- 12 March 2025
- Published by Wiley in Arthroscopy
- Vol. 41 (10) , 4095-4102
Intraoperative Periarticular Injection May Improve Postoperative Pain Scores and Reduce Opioid Consumption in Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery
Purpose: To evaluate efficacy of an intraoperative periarticular injection (PAI) in improving postoperative outcomes, including pain relief and reducing opioid consumption in patients undergoing arthroscopic anterior cruciate ligament reconstruction (aACLR) with hamstring tendon autograft. Methods: This prospective, assessor‐blinded, two‐surgeon clinical trial was conducted from March 20, 2022, to June 20, 2022. A total of 320 patients were initially included, and after screening and exclusions, 300 patients undergoing aACLR were randomized to receive either PAI or were assigned to the nPAI group. Inclusion criteria consisted of patients aged 18 years or older undergoing primary aACLR, with or without a concomitant meniscus procedure for knee instability, who agreed to participate and provided informed consent for randomization into the PAI or nPAI group. The minimum follow‐up period was 2 weeks postoperatively. The primary outcome was decreased visual analog scale (VAS) scores and cumulative morphine milligram equivalents (MME). The secondary outcome parameters included decrease in narcotic‐related adverse effects. Results: A total of 142 patients in the PAI group and 146 patients in the nPAI group were analyzed. In the PAI group, a lower VAS score at immediate postoperative period and postoperative 4‐hour and 24‐hour period was observed compared with the nPAI group. Proportions of patients achieving MCID were higher in the PAI group at all time points compared to nPAI. Cumulative morphine consumption was significantly reduced in the PAI group ( P < .001). Conclusions: PAI during aACLR with hamstring autograft significantly improved pain scores and reduced opioid consumption compared to nPAI. Although statistical differences were found, cohort‐specific MCID analysis showed a clinically relevant benefit at 24 hours, with 54.2% of the PAI group achieving meaningful pain relief versus 23.3% in the nPAI group. These results suggest that PAI offers time‐dependent, patient‐specific benefits and supports its role in multimodal analgesia. Level of Evidence: Level II, randomized controlled trials.
- 12 March 2025
- Published by Wiley in Arthroscopy
- Vol. 41 (10) , 4095-4102
Intraoperative Periarticular Injection May Improve Postoperative Pain Scores and Reduce Opioid Consumption in Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery
Purpose: To evaluate efficacy of an intraoperative periarticular injection (PAI) in improving postoperative outcomes, including pain relief and reducing opioid consumption in patients undergoing arthroscopic anterior cruciate ligament reconstruction (aACLR) with hamstring tendon autograft. Methods: This prospective, assessor‐blinded, two‐surgeon clinical trial was conducted from March 20, 2022, to June 20, 2022. A total of 320 patients were initially included, and after screening and exclusions, 300 patients undergoing aACLR were randomized to receive either PAI or were assigned to the nPAI group. Inclusion criteria consisted of patients aged 18 years or older undergoing primary aACLR, with or without a concomitant meniscus procedure for knee instability, who agreed to participate and provided informed consent for randomization into the PAI or nPAI group. The minimum follow‐up period was 2 weeks postoperatively. The primary outcome was decreased visual analog scale (VAS) scores and cumulative morphine milligram equivalents (MME). The secondary outcome parameters included decrease in narcotic‐related adverse effects. Results: A total of 142 patients in the PAI group and 146 patients in the nPAI group were analyzed. In the PAI group, a lower VAS score at immediate postoperative period and postoperative 4‐hour and 24‐hour period was observed compared with the nPAI group. Proportions of patients achieving MCID were higher in the PAI group at all time points compared to nPAI. Cumulative morphine consumption was significantly reduced in the PAI group ( P < .001). Conclusions: PAI during aACLR with hamstring autograft significantly improved pain scores and reduced opioid consumption compared to nPAI. Although statistical differences were found, cohort‐specific MCID analysis showed a clinically relevant benefit at 24 hours, with 54.2% of the PAI group achieving meaningful pain relief versus 23.3% in the nPAI group. These results suggest that PAI offers time‐dependent, patient‐specific benefits and supports its role in multimodal analgesia. Level of Evidence: Level II, randomized controlled trials.
- Open Access
- 8 March 2025
- Published by Springer Nature in Journal of Orthopaedics and Traumatology
- Vol. 26 (1) , 1-8
Effects of intra-articular tranexamic acid injection with different acting times after anterior cruciate ligament reconstruction: a cohort study with historical controls
Background: Intra-articular tranexamic acid (TXA) has been proven effective in reducing postoperative bleeding in anterior cruciate ligament reconstruction (ACLR). We aimed to evaluate the effect of intra-articular injection of TXA with different acting times after an ACLR procedure. Patients and methods: Patients receiving ACLR and intra-articular injection of TXA between September 2023 and January 2024 were randomly divided into two groups, with drainage clamped for 4 h (TXA 4 h group) or 8 h (TXA 8 h group). Postoperative drainage output was the primary outcome. The secondary outcomes included the visual analog scale (VAS), grade of hemarthrosis, and International Knee Documentation Committee (IKDC) functional score. The data of another two groups of patients (TXA 2 h group and placebo group) were retrieved from a previous study as historical control groups for subsequent analysis. Results: 121 patients were included. There were no significant differences in drainage output between TXA 4 h and TXA 8 h groups. On postoperative day 3, significantly decreased grades of hemarthrosis were noted in the TXA 8 h group (P = 0.030). There were no significant differences in the VAS at different postoperative time points or in the IKDC scores. Comparison with the placebo and TXA 2 h groups revealed significant reduction in postoperative drainage among the TXA 4 h and 8 h groups. The IKDC scores were significantly worse in the TXA 8 h group compared with the TXA 2 h (P < 0.001) and placebo (P = 0.009) groups. Conclusions: A 4 h clamping time for intra-articular TXA administration after ACLR may be considered in current practice, as it effectively reduces drainage and pain without negatively impacting functional outcomes. Level of evidence: Level III, cohort study.
- 8 March 2025
- Published by Springer Nature in Journal of Orthopaedics and Traumatology
- Vol. 26 (1) , 1-8
Open AccessEffects of intra-articular tranexamic acid injection with different acting times after anterior cruciate ligament reconstruction: a cohort study with historical controls
Background: Intra-articular tranexamic acid (TXA) has been proven effective in reducing postoperative bleeding in anterior cruciate ligament reconstruction (ACLR). We aimed to evaluate the effect of intra-articular injection of TXA with different acting times after an ACLR procedure. Patients and methods: Patients receiving ACLR and intra-articular injection of TXA between September 2023 and January 2024 were randomly divided into two groups, with drainage clamped for 4 h (TXA 4 h group) or 8 h (TXA 8 h group). Postoperative drainage output was the primary outcome. The secondary outcomes included the visual analog scale (VAS), grade of hemarthrosis, and International Knee Documentation Committee (IKDC) functional score. The data of another two groups of patients (TXA 2 h group and placebo group) were retrieved from a previous study as historical control groups for subsequent analysis. Results: 121 patients were included. There were no significant differences in drainage output between TXA 4 h and TXA 8 h groups. On postoperative day 3, significantly decreased grades of hemarthrosis were noted in the TXA 8 h group (P = 0.030). There were no significant differences in the VAS at different postoperative time points or in the IKDC scores. Comparison with the placebo and TXA 2 h groups revealed significant reduction in postoperative drainage among the TXA 4 h and 8 h groups. The IKDC scores were significantly worse in the TXA 8 h group compared with the TXA 2 h (P < 0.001) and placebo (P = 0.009) groups. Conclusions: A 4 h clamping time for intra-articular TXA administration after ACLR may be considered in current practice, as it effectively reduces drainage and pain without negatively impacting functional outcomes. Level of evidence: Level III, cohort study.
- Open Access
- 9 May 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (5) , 565
Global Compressive Loading from an Ultra-Thin PEEK Button Augment Enhances Fibrocartilage Regeneration of Rotator Cuff Enthesis
A PEEK button is developed to improve the tendon-to-bone compression area. In total, 18 goats were divided into 12-week, 4-week, and 0-week groups. All underwent bilateral detachment of the infraspinatus tendon. In the 12-week group, 6 were fixed with a 0.8–1 mm-thick PEEK augment (A-12, Augmented), and 6 were fixed with the double-row technique (DR-12). Overall, 6 infraspinatus were fixed with PEEK augment (A-4) and without PEEK augment (DR-4) in the 4-week group. The same condition was performed in the 0-week groups (A-0 and DR-0). Mechanical testing, immunohistochemistry assessment, cell responses, tissue alternation, surgical impact, remodeling, and the expression of type I, II, and III collagen of the native tendon-to-bone insertion and new footprint areas were evaluated. The average maximum load in the A-12 group (393.75 (84.40) N) was significantly larger than in the TOE-12 group (229.17 (43.94) N) (p < 0.001). Cell responses and tissue alternations in the 4-week group were slight. The new footprint area of the A-4 group had better fibrocartilage maturation and more type III collagen expression than in DR-4 group. This result proved the novel device is safe and provides superior load-displacement to the double-row technique. There is a trend toward better fibrocartilage maturation and more collagen III secretions in the PEEK augmentation group.
- 9 May 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (5) , 565
Open AccessGlobal Compressive Loading from an Ultra-Thin PEEK Button Augment Enhances Fibrocartilage Regeneration of Rotator Cuff Enthesis
A PEEK button is developed to improve the tendon-to-bone compression area. In total, 18 goats were divided into 12-week, 4-week, and 0-week groups. All underwent bilateral detachment of the infraspinatus tendon. In the 12-week group, 6 were fixed with a 0.8–1 mm-thick PEEK augment (A-12, Augmented), and 6 were fixed with the double-row technique (DR-12). Overall, 6 infraspinatus were fixed with PEEK augment (A-4) and without PEEK augment (DR-4) in the 4-week group. The same condition was performed in the 0-week groups (A-0 and DR-0). Mechanical testing, immunohistochemistry assessment, cell responses, tissue alternation, surgical impact, remodeling, and the expression of type I, II, and III collagen of the native tendon-to-bone insertion and new footprint areas were evaluated. The average maximum load in the A-12 group (393.75 (84.40) N) was significantly larger than in the TOE-12 group (229.17 (43.94) N) (p < 0.001). Cell responses and tissue alternations in the 4-week group were slight. The new footprint area of the A-4 group had better fibrocartilage maturation and more type III collagen expression than in DR-4 group. This result proved the novel device is safe and provides superior load-displacement to the double-row technique. There is a trend toward better fibrocartilage maturation and more collagen III secretions in the PEEK augmentation group.
- Open Access
- 20 October 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1503
Comparison of the Confluence-Initiated Neurogenic Differentiation Tendency of Adipose-Derived and Bone Marrow-Derived Mesenchymal Stem Cells
Adipose-derived mesenchymal stem cells (ADSCs), which tended to neurogenically differentiate spontaneously after achieving high confluence, were observed. Human ADSCs reaching 80% confluence were cultured in DMEM without an inducing factor for 24 h and then maintained in DMEM plus 1% FBS medium for 7 days. The neurogenic, adipogenic, and osteogenic genes of the factor-induced and confluence-initiated differentiation of the ADSCs and bone marrow-derived mesenchymal stem cells (BMSCs) at passages 3 to 5 were determined and compared using RT-qPCR, and the neurogenic differentiation was confirmed using immunofluorescent staining. In vitro tests revealed that the RNA and protein expression of neuronal markers, including class III β-tubulin (TUBB3), microtubule-associated protein 2 (MAP2), neurofilament medium polypeptide (NEFM), neurofilament heavy polypeptide (NEFH), and neurofilament light polypeptide (NEFL), had been enhanced in the confluence-initiated differentiation of the ADSCs. In addition, the expressions of neurotrophins, such as the nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF), were also elevated in the confluence-initiated differentiation of the ADSCs. However, the confluent ADSCs did not show a tendency toward spontaneous adipogenic and osteogenic differentiation. Moreover, compared with the confluent ADSCs, the tendency of spontaneous neurogenic, adipogenic, and osteogenic differentiation of the confluent human bone marrow mesenchymal stem cells (BMSCs) was not observed. The results indicated that ADSCs had the potential to spontaneously differentiate into neuron-like cells during the confluent culture period; however, this tendency was not observed in BMSCs.
- 20 October 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1503
Open AccessComparison of the Confluence-Initiated Neurogenic Differentiation Tendency of Adipose-Derived and Bone Marrow-Derived Mesenchymal Stem Cells
Adipose-derived mesenchymal stem cells (ADSCs), which tended to neurogenically differentiate spontaneously after achieving high confluence, were observed. Human ADSCs reaching 80% confluence were cultured in DMEM without an inducing factor for 24 h and then maintained in DMEM plus 1% FBS medium for 7 days. The neurogenic, adipogenic, and osteogenic genes of the factor-induced and confluence-initiated differentiation of the ADSCs and bone marrow-derived mesenchymal stem cells (BMSCs) at passages 3 to 5 were determined and compared using RT-qPCR, and the neurogenic differentiation was confirmed using immunofluorescent staining. In vitro tests revealed that the RNA and protein expression of neuronal markers, including class III β-tubulin (TUBB3), microtubule-associated protein 2 (MAP2), neurofilament medium polypeptide (NEFM), neurofilament heavy polypeptide (NEFH), and neurofilament light polypeptide (NEFL), had been enhanced in the confluence-initiated differentiation of the ADSCs. In addition, the expressions of neurotrophins, such as the nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF), were also elevated in the confluence-initiated differentiation of the ADSCs. However, the confluent ADSCs did not show a tendency toward spontaneous adipogenic and osteogenic differentiation. Moreover, compared with the confluent ADSCs, the tendency of spontaneous neurogenic, adipogenic, and osteogenic differentiation of the confluent human bone marrow mesenchymal stem cells (BMSCs) was not observed. The results indicated that ADSCs had the potential to spontaneously differentiate into neuron-like cells during the confluent culture period; however, this tendency was not observed in BMSCs.
- 24 April 2021
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 17 (5) , 1796-1809
Adipose Derived Mesenchymal Stem Cells from a Hypoxic Culture Reduce Cartilage Damage
The method to benifit tissue engineering of adipose-derived stem cells (ADSCs) to cartilage has been an objective of intense research in treating increasing cartilage-related disease. In this study, whether hypoxic expansion would enhance the proliferation and in vitro chondrogenic differentiation of ADSCs was studied, and then hypoxic expansion was applied to reduce cartilage damage in a rat model in vivo. Hypoxic expansion increased the proliferation and decreased the expression of aging-related genes, including p16, p21, and p53, of human ADSCs in comparison with normoxic expansion. In addition, the γH2AX expression was reduced in the hypoxic ADSCs. The chondrogenic markers were enhanced in the hypoxic ADSC differentiated chondrogenic pellets, including SOX9 on day 7 and gene expressions of COL 2 and COL 10 on day 21. To determine the in vitro chondrogenic differentiation potential of ADSCs, ADSC differentiated 21-day chondrogenic pellets were stained by Alcian blue staining and the immunostaining of COL 2 and COL 10, the results of which confirmed the enhancement of differentiation potential after the hypoxic expansion. Moreover, cartilage injury in a rat model was reduced by hypoxic ADSC treatment that was determined by histological and immunohistochemical staining detections. The effects of hypoxic expansion of ADSCs and bone marrow-derived stem cells (BMSCs) on chondrogenic differentiation potential were also compared. Smaller sizes were presented in the in vitro hypoxic BMSC differentiated chondrogenic pellets, whereas the chondrogenic marker expressions were significantly higher than those of the hypoxic ADSCs. However, there was no significant difference between the treatments of the hypoxic ADSCs and BMSCs in the cartilage injury in vivo. In conclusion, hypoxic expansion increases the chondrogenic differentiation potential of ADSCs and BMSCs in vitro and enhances them to reduce cartilage damage in vivo. Although the hypoxic BMSCs showed compact chondrogenic pellet formation and higher potential of chondrogenesis, the easy access and large resources of ADSCs still uplifted the application. Graphical Abstract
- 24 April 2021
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 17 (5) , 1796-1809
Adipose Derived Mesenchymal Stem Cells from a Hypoxic Culture Reduce Cartilage Damage
The method to benifit tissue engineering of adipose-derived stem cells (ADSCs) to cartilage has been an objective of intense research in treating increasing cartilage-related disease. In this study, whether hypoxic expansion would enhance the proliferation and in vitro chondrogenic differentiation of ADSCs was studied, and then hypoxic expansion was applied to reduce cartilage damage in a rat model in vivo. Hypoxic expansion increased the proliferation and decreased the expression of aging-related genes, including p16, p21, and p53, of human ADSCs in comparison with normoxic expansion. In addition, the γH2AX expression was reduced in the hypoxic ADSCs. The chondrogenic markers were enhanced in the hypoxic ADSC differentiated chondrogenic pellets, including SOX9 on day 7 and gene expressions of COL 2 and COL 10 on day 21. To determine the in vitro chondrogenic differentiation potential of ADSCs, ADSC differentiated 21-day chondrogenic pellets were stained by Alcian blue staining and the immunostaining of COL 2 and COL 10, the results of which confirmed the enhancement of differentiation potential after the hypoxic expansion. Moreover, cartilage injury in a rat model was reduced by hypoxic ADSC treatment that was determined by histological and immunohistochemical staining detections. The effects of hypoxic expansion of ADSCs and bone marrow-derived stem cells (BMSCs) on chondrogenic differentiation potential were also compared. Smaller sizes were presented in the in vitro hypoxic BMSC differentiated chondrogenic pellets, whereas the chondrogenic marker expressions were significantly higher than those of the hypoxic ADSCs. However, there was no significant difference between the treatments of the hypoxic ADSCs and BMSCs in the cartilage injury in vivo. In conclusion, hypoxic expansion increases the chondrogenic differentiation potential of ADSCs and BMSCs in vitro and enhances them to reduce cartilage damage in vivo. Although the hypoxic BMSCs showed compact chondrogenic pellet formation and higher potential of chondrogenesis, the easy access and large resources of ADSCs still uplifted the application. Graphical Abstract